Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Metab Pharmacokinet ; 35(1): 117-123, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31974045

ABSTRACT

The blood-brain barrier (BBB) transport systems regulate the supply of nutrients, amino acids, vitamins, and hormones to the developing brain, as well as blocking the entry of xenobiotics and drugs. The purpose of this study was to clarify the developmental changes in the absolute protein expression levels of BBB transport-related proteins in developing rat brain capillaries, using quantitative targeted absolute proteomics (QTAP). The changing patterns of ATP-binding cassette (ABC) and solute carrier (SLC) transporters, receptors, and tight junction/adherence junction-related proteins were classified into 4 types: uphill (continuously increasing expression from postnatal day (P) 1 to P56), bell-shape/inverted bell-shape (increased/decreased expression from P1 to P14 followed by decreased/increased expression from P21 to P56), downhill (continuously decreasing expression from P1 to P56), and constant (no significant difference from P1 to P56). Proteins showing uphill-type expression included P-glycoprotein/Mdr1a/Abcb1, Mrp4/Abcc4, Bcrp/Abcg2, Glut1/Slc2a1, Oatp1c1/Slco1c1, FcRn, 4F2hc/Slc3a2, claudin-5, caveolin-1, Cd29/integrin ß1. Those showing bell-shape/inverted bell-shape expression included Mct1/Slc16a1, Oat3/Slc22a8, Tfr1, Lrp1, and CD147. On the other hand, Cat1/Slc7a1 and Cd54/Icam-1 showed downhill expression, and Insr showed constant expression. These results suggest that the protein expression levels of transporters and receptors at the BBB change in various ways to meet the changing requirements of the developing brain.


Subject(s)
Blood-Brain Barrier/metabolism , Membrane Transport Proteins/biosynthesis , Proteomics , Receptors, Cell Surface/biosynthesis , Animals , Female , Male , Membrane Transport Proteins/analysis , Rats , Rats, Wistar , Receptors, Cell Surface/analysis
2.
Microvasc Res ; 117: 16-21, 2018 05.
Article in English | MEDLINE | ID: mdl-29247719

ABSTRACT

l-Arginine is required for regulating synapse formation/patterning and angiogenesis in the developing brain. We hypothesized that this requirement would be met by increased transporter-mediated supply across the blood-brain barrier (BBB). Thus, the purpose of this work was to test the idea that elevation of blood-to-brain l-arginine transport across the BBB in the postnatal period coincides with up-regulation of cationic acid transporter 1 (CAT1) expression in developing brain capillaries. We found that the apparent brain-to-plasma concentration ratio (Kp, app) of l-arginine after intravenous administration during the first and second postnatal weeks was 2-fold greater than that at the adult stage. Kp, app of l-serine was also increased at the first postnatal week. In contrast, Kp, app of d-mannitol, a passively BBB-permeable molecule, did not change, indicating that increased transport of l-arginine and l-serine is not due to BBB immaturity. Double immunohistochemical staining of CAT1 and a marker protein, glucose transporter 1, revealed that CAT1 was localized on both luminal and abluminal membranes of brain capillary endothelial cells during the developmental and adult stages. A dramatic increase in CAT1 expression in the brain was seen at postnatal day 7 (P7) and day 14 (P14) and the expression subsequently decreased as the brain matured. In accordance with this, intense immunostaining of CAT1 was observed in brain capillaries at P7 and P14. These findings strongly support our hypothesis and suggest that the supply of blood-born l-arginine to the brain via CAT1 at the BBB plays a key role in meeting the elevated demand for l-arginine in postnatal brain.


Subject(s)
Arginine/metabolism , Blood-Brain Barrier/metabolism , Capillaries/metabolism , Cationic Amino Acid Transporter 1/metabolism , Endothelial Cells/metabolism , Age Factors , Animals , Arginine/administration & dosage , Arginine/blood , Biological Transport , Blood-Brain Barrier/embryology , Capillaries/embryology , Cationic Amino Acid Transporter 1/genetics , Gene Expression Regulation, Developmental , Gestational Age , Injections, Intravenous , Male , Rats, Wistar , Up-Regulation
3.
PLoS One ; 7(2): e32557, 2012.
Article in English | MEDLINE | ID: mdl-22384273

ABSTRACT

Guanidinoacetic acid (GAA) is the biosynthetic precursor of creatine which is involved in storage and transmission of phosphate-bound energy. Hepatocytes readily convert GAA to creatine, raising the possibility that the active uptake of GAA by hepatocytes is a regulatory factor. The purpose of this study is to investigate and identify the transporter responsible for GAA uptake by hepatocytes. The characteristics of [(14)C]GAA uptake by hepatocytes were elucidated using the in vivo liver uptake method, freshly isolated rat hepatocytes, an expression system of Xenopus laevis oocytes, gene knockdown, and an immunohistochemical technique. In vivo injection of [(14)C]GAA into the rat femoral vein and portal vein results in the rapid uptake of [(14)C]GAA by the liver. The uptake was markedly inhibited by γ-aminobutyric acid (GABA) and nipecotinic acid, an inhibitor of GABA transporters (GATs). The characteristics of Na(+)- and Cl(-)-dependent [(14)C]GAA uptake by freshly isolated rat hepatocytes were consistent with those of GAT2. The Km value of the GAA uptake (134 µM) was close to that of GAT2-mediated GAA transport (78.9 µM). GABA caused a marked inhibition with an IC(50) value of 8.81 µM. The [(14)C]GAA uptake exhibited a significant reduction corresponding to the reduction in GAT2 protein expression. GAT2 was localized on the sinusoidal membrane of the hepatocytes predominantly in the periportal region. This distribution pattern was consistent with that of the creatine biosynthetic enzyme, S-adenosylmethionine:guanidinoacetate N-methyltransferase. GAT2 makes a major contribution to the sinusoidal GAA uptake by periportal hepatocytes, thus regulating creatine biosynthesis in the liver.


Subject(s)
GABA Plasma Membrane Transport Proteins/physiology , Glycine/analogs & derivatives , Animals , Biological Transport , Female , Femoral Vein/pathology , GABA Plasma Membrane Transport Proteins/metabolism , Glycine/metabolism , Hepatocytes/metabolism , Immunohistochemistry/methods , Kinetics , Male , Models, Biological , Models, Genetic , Oocytes/cytology , RNA Interference , Rats , Rats, Wistar , Xenopus laevis
4.
J Neurochem ; 118(2): 304-13, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21592122

ABSTRACT

D-Serine is a co-agonist for NMDA-type glutamate receptors. Although D-serine levels in CSF and interstitial fluid (ISF) affect CNS function, the regulatory system remains to be fully understood. Therefore, the purpose of this study was to investigate d-serine transport across the blood-brain barrier (BBB) and blood-CSF barrier (BCSFB) and in brain parenchymal cells. D-Serine microinjected into the cerebrum was not eliminated, suggesting a negligible contribution of D-serine efflux transport at the BBB. In contrast, D-serine was taken up from the circulating blood across the BBB via a carrier-mediated process. D-Serine elimination clearance from CSF was fourfold greater than that of d-mannitol, which is considered to reflect CSF bulk flow. The characteristics of D-serine uptake by isolated choroid plexus were consistent with those of Na(+)-independent alanine-serine-cysteine transporter 1 (asc-1). Uptake of D-serine by brain slices appeared to occur predominantly via asc-1 and Na(+)-dependent alanine-serine-cysteine transporter 2. These findings suggest that the regulatory system of D-serine levels in ISF and CSF involves (i) asc-1 at the BCSFB, acting as a major pathway of D-serine elimination from the CSF, (ii) blood-to-brain and blood-to-CSF influx transport of D-serine across the BBB and BCSFB, and (iii) concentrative uptake of D-serine by brain parenchymal cells.


Subject(s)
Blood-Brain Barrier/cytology , Blood-Brain Barrier/metabolism , Choroid Plexus/cytology , Choroid Plexus/metabolism , Serine/metabolism , Animals , Biological Transport, Active/physiology , Injections, Intraventricular , Male , Mice , Mice, Inbred Strains , Rats , Rats, Wistar , Serine/administration & dosage , Serine/cerebrospinal fluid
5.
J Pharm Sci ; 100(9): 3892-903, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21590774

ABSTRACT

D-serine, a coagonist for N-methyl-D-aspartate-type glutamate receptors, which mediate visual signal transmission, is thought to be generated from L-serine via serine racemase in the retina. However, the source of L-serine and D-serine in the retina are yet to be determined. The purpose of the present study was to investigate the characteristics of the blood-to-retina transport of serine at the inner blood-retinal barrier (BRB). In vivo study revealed the blood-to-retina transport of [(3) H]L-serine with an influx clearance of 49.9 µL/(min·g retina), which is greater than that of [(3) H]D-serine. This was consistent with the L-isomer-predominant uptake of serine by conditionally immortalized rat retinal capillary endothelial cell line (TR-iBRB2 cells), an in vitro inner BRB model. [(3) H]L-Serine and [(3) H]D-serine uptake by TR-iBRB2 cells took place in an Na(+)-dependent and a concentration-dependent manner with Michaelis constant values of 97.5 µM and 9.63 mM, respectively. The uptake process of [(3) H]L-serine and [(3) H]D-serine was significantly inhibited by system ASC (alanine-serine-cysteine) substrates. Polymerase chain reaction analysis and immunocytochemistry revealed the expression of ASC transporters ASCT1 and ASCT2 in TR-iBRB2 cells. These results suggest that the system ASC at the inner BRB is a potent pathway for supplying serine in the form of the L-isomer from the circulating blood to the retina.


Subject(s)
Blood-Retinal Barrier , Serine/pharmacokinetics , Animals , Base Sequence , Cell Line, Transformed , DNA Primers , Immunohistochemistry , Isomerism , Male , Models, Biological , Polymerase Chain Reaction , Rats , Rats, Wistar , Serine/chemistry
6.
Neurochem Int ; 57(3): 262-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20558222

ABSTRACT

We have reported previously that creatine is biosynthesized from glycine and L-arginine in Müller cells, but the mechanism responsible for glycine and L-arginine uptake by Müller cells remains elusive. To explore this issue, [(14)C]glycine and [(3)H]L-arginine uptake by Müller cells was characterized using a conditionally immortalized rat Müller cell line (TR-MUL5 cells). [(14)C]Glycine uptake by TR-MUL5 cells was Na(+)- and Cl(-)-dependent, and a saturable process with Michaelis-Menten constants of 48.6 microM and 4.53 mM, and inhibited by glycine transporter 1 (GlyT1) and system A substrates. Under Cl(-)-free conditions, the high-affinity process was abolished. RT-PCR analysis demonstrated that GlyT1 and system A (encoding ATA1 and ATA2) mRNA are expressed in TR-MUL5 cells. These uptake studies suggest that GlyT1 and system A are involved in [(14)C]glycine uptake for the high- and low-affinity processes, respectively, in TR-MUL5 cells. [(3)H]l-Arginine uptake by TR-MUL5 cells was primarily an Na(+)-independent and saturable process with Michaelis-Menten constants of 15.0 and 403 microM. This process was inhibited by substrates of cationic amino acid transporter (CAT)s, such as L-arginine, L-lysine, and L-ornithine. The expression of CAT1 protein was detected in TR-MUL5 cells. These results suggest that CAT1 is at least involved in [(3)H]l-arginine uptake by TR-MUL5 cells. In conclusion, GlyT1 and CAT1 most likely mediate glycine and L-arginine uptake, respectively, by Müller cells and are expected to play an important role in supplying precursors for creatine biosynthesis in Müller cells.


Subject(s)
Amino Acid Transport Systems/genetics , Amino Acid Transport Systems/metabolism , Arginine/metabolism , Glycine/metabolism , Neuroglia/metabolism , Amino Acid Transport System A/genetics , Amino Acid Transport System A/metabolism , Animals , Biological Transport, Active , Blotting, Western , Cells, Cultured , DNA/biosynthesis , DNA/genetics , Data Interpretation, Statistical , Dose-Response Relationship, Drug , Glycine Plasma Membrane Transport Proteins/genetics , Glycine Plasma Membrane Transport Proteins/metabolism , Indicators and Reagents , Kinetics , Male , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , TRPV Cation Channels/genetics , TRPV Cation Channels/metabolism
7.
J Neurochem ; 111(3): 716-25, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19712052

ABSTRACT

The purpose of this study was to identify the transporter mediating l-arginine transport at the inner blood-retinal barrier (BRB). The apparent uptake clearance of [(3)H]L-arginine into the rat retina was found to be 118 microL/(min.g retina), supporting a carrier-mediated influx transport of L-arginine at the BRB. [(3)H]L-arginine uptake by a conditionally immortalized rat retinal capillary endothelial cell line (TR-iBRB2 cells), used as an in vitro model of the inner BRB, was primarily an Na(+)-independent and saturable process with Michaelis-Menten constants of 11.2 microM and 530 microM. This process was inhibited by rat cationic amino acid transporter (CAT) 1-specific small interfering RNA as well as substrates of CATs, L-arginine, L-lysine, and L-ornithine. The expression of cationic amino acid transporter (CAT) 1 mRNA was 25.9- and 796-fold greater than that of CAT3 in TR-iBRB2 and magnetically isolated rat retinal vascular endothelial cells, respectively. The expression of CAT1 protein was detected in TR-iBRB2 cells and immunostaining of CAT1 was observed along the rat retinal capillaries. In conclusion, CAT1 is localized in retinal capillary endothelial cells and at least in part mediates L-arginine transport at the inner BRB. This process seems to be closely involved in visual functions by supplying precursors of biologically important molecules like nitric oxide in the neural retina.


Subject(s)
Arginine/metabolism , Blood-Retinal Barrier/physiology , Cationic Amino Acid Transporter 1/physiology , Retina/metabolism , Animals , Biological Transport/drug effects , Blood-Retinal Barrier/drug effects , Cationic Amino Acid Transporter 1/genetics , Cells, Cultured , Chromatography, High Pressure Liquid/methods , Gene Expression Regulation/drug effects , Humans , Male , RNA, Small Interfering/pharmacology , Rats , Rats, Wistar , Retina/cytology , Retina/drug effects , Retinal Vessels/cytology , Time Factors , Transfection/methods , Tritium/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...